Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma
Author
Lutfi, ForatHoltzman, Noa
Siglin, Jonathan
Bukhari, Ali
Mustafa Ali, Moaath
Kim, Dong
Sanchez-Petitto, Gabriela
Gottlieb, David
Ruehle, Kathleen
Hutnick, Elizabeth
Gahres, Natalie
Hankey, Kim
Lee, Seung
Kocoglu, Mehmet
Yared, Jean
Hardy, Nancy
Rapoport, Aaron
Dahiya, Saurabh
Date
2020-11-10Journal
British Journal of HaematologyPublisher
Blackwell PublishingType
Article
Metadata
Show full item recordIdentifier to cite or link to this item
http://hdl.handle.net/10713/14196ae974a485f413a2113503eed53cd6c53
10.1111/bjh.17121
Scopus Count
Collections
Related articles
- Immunotherapies Old and New: Hematopoietic Stem Cell Transplant, Chimeric Antigen Receptor T Cells, and Bispecific Antibodies for the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma.
- Authors: Doraiswamy A, Shah MR, Bannerji R
- Issue date: 2021 Feb
- Cellular Therapy in Follicular Lymphoma: Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, and Chimeric Antigen Receptor T-cell Therapy.
- Authors: Okosun J, Montoto S
- Issue date: 2020 Aug
- Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy.
- Authors: Shadman M, Gauthier J, Hay KA, Voutsinas JM, Milano F, Li A, Hirayama AV, Sorror ML, Cherian S, Chen X, Cassaday RD, Till BG, Gopal AK, Sandmaier BM, Maloney DG, Turtle CJ
- Issue date: 2019 Oct 22
- Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma.
- Authors: Jain T, Sauter CS, Shah GL, Maloy MA, Chan J, Scordo M, Avecilla ST, Batlevi Y, Dahi PB, Batlevi CW, Lia Palomba M, Giralt SA, Perales MA
- Issue date: 2019 Oct
- Use of chimeric antigen receptor T cells in allogeneic hematopoietic stem cell transplantation.
- Authors: Liu J, Zhang X, Zhong JF, Zhang C
- Issue date: 2019 Jan